Leerink, Global Healthcare

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will present a company overview at the Leerink Partners Global Healthcare Conference on Wednesday,
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in March as follows:
MindMed to Present at Leerink’s Global Healthcare Conference 2025
An announcement from Mind Medicine ( ($MNMD) ) is now available. MindMed has announced its participation in Leerink’s Global Healthcare Conference
Belite Bio to Participate in the Leerink Partners Global Healthcare Conference
Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs,
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2025
CHARLOTTE, N.C., March 04, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 11, 2025, at 3:00 pm ET.
Premier, Inc. to Participate in Leerink Global Healthcare Conference on March 11, 2025
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will par
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company's management team will present and participate in 1x1 investor meetings at the Leerink Partners Global Healthcare Conference,
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures.
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer,
Morningstar2d
AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference
Eric Easom, Co-Founder, Chairman, President and CEO, will provide a corporate overview on Wednesday, March 12, 2025 at 2:20 pm ET, and members of management will be available for 1X1 meetings. A ...
Nasdaq2d
NeuroPace, Inc. to Present at Leerink Partners 2025 Global Healthcare Conference
announced that its management will present at the Leerink Partners 2025 Global Healthcare Conference on March 10, 2025, in Miami, FL, at 4:20 PM ET. During the conference, they will also ...
Business Wire7d
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
(“Innate” or the “Company”) today announced that members of its executive team will present and host 1x1 meetings at the Leerink Partners 2025 Global Healthcare Conference being held on ...
Morningstar2d
Contineum Therapeutics to Present at the 2025 Leerink Partners Global Healthcare Conference
We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. How we use your information depends on the product and service ...